NCT04678440View on ClinicalTrials.gov

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

February 7, 2023

Study Completion Date

February 7, 2023

Conditions
Lung Cancer, Nonsmall Cell
Interventions
DRUG

[18F]F-AraG Imaging

Total body PET imaging using \[18F\]F-AraG

Trial Locations (1)

95816

UC Davis EXPLORER Molecular Imaging Center, Sacramento

Sponsors
All Listed Sponsors
collaborator

CellSight Technologies, Inc.

INDUSTRY

lead

University of California, Davis

OTHER